Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-718-4 | CAS number: 7699-45-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Direct observations: clinical cases, poisoning incidents and other
Administrative data
- Endpoint:
- direct observations: clinical cases, poisoning incidents and other
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- Not reported
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for data waiving:
- other:
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 961
Materials and methods
- Study type:
- clinical case study
- Endpoint addressed:
- acute toxicity: inhalation
Test guideline
- Qualifier:
- no guideline required
- Principles of method if other than guideline:
- Acase report of chemical pneumonitis from overexposure of smoke containing zinc chloride in three young airmen has been presented.
- GLP compliance:
- no
Test material
- Reference substance name:
- Zinc chloride
- EC Number:
- 231-592-0
- EC Name:
- Zinc chloride
- Cas Number:
- 7646-85-7
- IUPAC Name:
- zinc dichloride
- Details on test material:
- - Name of test material (as cited in study report): Smoke containing zinc chloride
Constituent 1
Method
- Type of population:
- occupational
- Subjects:
- - Number of subjects exposed: Three
- Sex: Male
- Age: 17, 17 and 19 yr, respectively
- Demographic information: United States
- Other: Occupation - Airman - Ethical approval:
- not applicable
- Route of exposure:
- inhalation
- Reason of exposure:
- unintentional, occupational
- Exposure assessment:
- measured
- Details on exposure:
- Over exposure to screening smoke containing zinc chloride in first two cases and 5 min. exposure to smoke in third case.
Analysis of air sample at scene of exposure:
Total particulate matter: 800 mg/m3 (average size 0.1 micron.)
Aluminum chloride: 334.2 mg/m3
Aluminum oxide: 134.6 mg/m3
Zinc chloride: 4075.0 mg/m3
Zinc oxide: 107.6 mg/m3 - Examinations:
- Routine laboratory examinations; chest X-ray; lung functional parameters; zinc urinary excretion; repeated throat and sputum cultures
- Medical treatment:
- Case 1:
Treatment 1: Supportive therapy upon initial hospitalization
Treatment 2: Saturated solution of potassium iodide and tetracycline initially upon re-admission with intermittent positive pressure breathing with 100 % oxygen.
Treatment 3: 250 mg of hydrocortisone intravenously over the next 14 h with intermittent positive pressure breathing.
Treatment 4: Positive pressure breathing continued intermittently for the next 5 d and steroid administration in the form of oral prednisolone was continued for 12 d.
Case 2:
Symptomatic treatment with elixir of terpin hydrate and aspirin
Case 3:
Symptomatic treatment with elixir of terpin hydrate and salicylates
Results and discussion
- Clinical signs:
- Case 1: Burning of the throat, paroxysmal coughing, nausea and retching after exposure. Only abnormal physical findings observed upon hospitalisation 1 h after exposure were increased oral temperature (99.6 ºF) and respiratory rate (26 per min.). Symptoms of coughing and nausea disappeared rapidly on supportive therapy (returned to duty). During the next 48 h, increased dyspnea, feverishness, and malaise noticed (re-admitted). The only abnormal physical finding upon re-admission was an oral temperature of 102.6 ºF.
Case 2: Cough, dyspnea and burning of the throat after exposure. Only abnormal physical findings observed upon hospitalization 1.5 h after exposure were increased oral temperature (101.0 ºF), respiratory rate (38 per min), and mildly injected pharyngeal mucosa. Dyspnea, coughing and mild malaise disappeared within 6 h, but temperature remained elevated (up to 101.6 ºF) and a few rales were heard in the left lung base.
Case 3: Breathlessness, nausea, cough and tightness of the chest, shortly after a 5 min exposure. Only abnormal physical findings observed upon hospitalisation shortly after exposure were tachypnea, medium pitched expiratory ronchi and mild obesity. The temperature was normal and no cyanosis was seen. The tachypnea, nausea, and coughing diminished later on the day of hospitalisation, although the temperature rose to 102 ºF in the absence of any new symptom. Except for an occasional ronchus which was heard only early in the hospitalisation, auscultation and percussion of the chest were non-revealing. Mild malaise, dyspnea and a nonproductive cough with slight fever were present during the first 72 h, but thereafter no symptoms were observed. - Results of examinations:
- Case 1:
Routine laboratory results: Normal except for white blood count of 11,700 cells/mm3. The differential white blood count showed a shift to the left and a 6 % eosinophilia.
Chest X-ray: A moderately dense, diffuse infiltrative process throughout both lung fields upon re-admission which progressed afterwards. Initial clearing of the infiltrate was not observed for 11 d, and final resolution was delayed for over one month.
Repeated throat and sputum cultures: Normal flora
Lung functional parameters: Only pulmonary ventilatory abnormality was reduced vital capacity (75.8 % of the predicted normal value), which later increased to 99.6 % of the predicted normal value after convalescence.
24 h zinc urinary excretion: 3.02 mg during early convalescence (upper limits of normal 1.0 mg/d).
Case 2:
Routine laboratory results: Normal except elevated white blood count of 11,800 cells/mm3 and an increase in the % of polymorphonuclear cells on differential count.
Chest X-ray: Normal on second day of hospitalisation. Faint, diffuse infiltrate in the left mid-lung field next day. Increase in the patchy infiltration in the left mid-lung field with a fainter infiltration in the opposite side after 5 d. Radiographic resolution was virtually complete in one month.
Lung functional parameters: Borderline normal vital capacity (82 % of predicted normal levels), and a resting blood oxyhemoglobin saturation of 97.7 % at the height of lung infiltration. After recovery the vital capacity improved to the level of 95 % of predicted normal.
24 h Zinc urinary excretion: 1.74 mg (highest)
Case 3:
Routine laboratory results: Normal
Chest X-ray: Infiltrative process involving the left lower lung field and lingula and mild dorsal scoliosis after 24 h of hospitalization. More generalised extension of the infiltrate after 4 d. Radiographic resolution was virtually complete in 16 d.
Lung functional parameters: The only pulmonary ventilatory function abnormality was reduced vital capacity (65.8 % of the predicted normal value), which improved to 87.3 % after recovery. Resting blood oxyhemoglobin saturation was 94.5 % at the height of the clinical illness.
Repeated throat and sputum cultures: Normal bacterial flora. Absence of cold agglutinins and non-significant titres of respiratory virus agglutinations indicated non-viral pneumonitis. - Effectivity of medical treatment:
- Case 1:
Treatment 1: Symptoms of coughing and nausea disappeared rapidly. However, during the next 48 h, increased dyspnea, feverishness, and malaise.
Treatment 2: Only a rare non-productive cough, temperature climbed to 105.2 ºF and developed tachypnea and definite cyanosis. A repeat chest x-ray film after treatment showed progression of infiltrate, definite cyanosis. Intermittent positive pressure breathing showed little effect.
Treatment 3: The temperature dropped 2 ºF within 1 h of this treatment and was normal within 6 h. Tachypnea decreased and color improved concomitantly.
Treatment 4: A low grade tachypnea and sporadic temperature elevations (up to 101.0 ºF) continued for the first 72 h. After this, the patient was essentially asymptomatic. In spite of marked earlier clinical improvement, initial clearing of the infiltrate was not observed for 11 d, and final resolution was delayed for over one month.
Case 2: Only symptomatic treatment was given. Patient was virtually asymptomatic after 4 d.
Case 3. Only symptomatic treatment was given. Patient was virtually asymptomatic after 72 h. - Outcome of incidence:
- Case 1: Asymptomatic within a wk but radiographic resolution was delayed over 1 month.
Case 2: Afebrile and asymptomatic after 4 d and radiographic resolution was virtually complete in one month.
Case 3: Virtually asymptomatic after 72 h and radiographic resolution was virtually complete in 16 d.
Any other information on results incl. tables
None
Applicant's summary and conclusion
- Conclusions:
- Not applicable
- Executive summary:
Three cases of severe, generalised chemical pneumonitis resulting from exposure to zinc chloride smoke were presented.
In all three of them, the initial symptoms such as nausea, paroxysmal cough, dyspnea and tightness of the chest, disappeared after 6 h of conservative care. However, fever, tachypnea and cyanosis developed later and were particularly noticeable in the first patient. Later, in the course of the illness, coughing was non-productive and infrequent despite the presence of marked parenchymal infiltration on the X-rays. Auscultation of the lungs revealed only occasional ronchi and a few medium rales in one patient despite the density of the pneumonitis suggested by the x-ray film. The depressed vital capacity during the acute illness reverted to normal in all patients.
Two responded to symptomatic treatment while under close observation and one showed rapid progression and demanded the most aggressive measures. Despite the generalised involvement in all three patients and the relatively long persistence of infiltrate on chest x-rays, no lasting effects were detected by analysis of follow-up symptoms, chest x-ray films, ventilatory function tests or blood gas studies.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
